Protein folding and mechanisms of proteostasis

International Journal of Molecular Sciences

Volumn 16, Issue 8, 2015, Pages 17193-17230

  Díaz Villanueva, José Fernando ^a   Díaz Molina, Raúl ^a   García González, Victor ^a  

^a UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

Author keywords

Folding; Misfolding; Proteins; Proteostasis

Indexed keywords

4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE; 4 PHENYLBUTYRIC ACID; AMYLOID; CHAPERONE; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK TRANSCRIPTION FACTOR 1; INTRINSICALLY DISORDERED PROTEIN; PREALBUMIN; PROTEIN P53; TAFAMIDIS; TAUROURSODEOXYCHOLIC ACID;

ALLOSTERISM; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CELL COMPARTMENTALIZATION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM STRESS; FEEDBACK SYSTEM; ION TRANSPORT; MOLECULAR RECOGNITION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN STRUCTURE; REVIEW; RNA PROCESSING; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE; X RAY DIFFRACTION; ANIMAL; CHEMISTRY; HOMEOSTASIS; HUMAN; METABOLISM; PROTEIN UNFOLDING;

ANIMALS; HOMEOSTASIS; HUMANS; MOLECULAR CHAPERONES; PROTEIN UNFOLDING; UNFOLDED PROTEIN RESPONSE;

EID: 84938117658     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160817193     Document Type: Review

References (256)

1. Badyaev, A.V. Stress-induced variation in evolution: From behavioural plasticity to genetic assimilation. Proc. Biol. Sci. 2005, 272, 877–886
2. Nussinov, R. The spatial structure of cell signaling systems. Phys. Biol. 2013, 10, 045004
3. Nussinov, R.; Wolynes, P.G. A second molecular biology revolution? The energy landscapes of biomolecular function. Phys. Chem. Chem. Phys. 2014, 16, 6321–6322
4. Rutkowski, D.T.; Hegde, R.S. Regulation of basal cellular physiology by the homeostatic unfolded protein response. J. Cell Biol. 2010, 189, 783–794
5. Dobson, C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24, 329–332
6. Seong, S.Y.; Matzinger, P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4, 469–478
7. Campioni, S.; Mannini, B.; Zampagni, M.; Pensalfini, A.; Parrini, C.; Evangelisti, E.; Relini, A.; Stefani, M.; Dobson, C.M.; Cecchi, C.; et al. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 2010, 6, 140–147
8. Cheon, M.; Chang, I.; Mohanty, S.; Luheshi, L.M.; Dobson, C.M.; Vendruscolo, M.; Favrin, G Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput. Biol. 2007, 3, 1727–1738
9. Olzscha, H.; Schermann, S.M.; Woerner, A.C.; Pinkert, S.; Hecht, M.H.; Tartaglia, G.G.; Vendruscolo, M.; Hayer-Hartl, M.; Hartl, F.U.; Vabulas, R.M. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 2011, 144, 67–78
10. Narayan, P.; Ganzinger, K.A.; McColl, J.; Weimann, L.; Meehan, S.; Qamar, S.; Carver, J.A.; Wilson, M.R.; St George-Hyslop, P.; Dobson, C.M. et al. Single molecule characterization of the interactions between amyloid-β peptides and the membranes of hippocampal cells. J. Am Chem. Soc. 2013, 135, 1491–1498
11. Liu, Y.; Ye, Y. Proteostasis regulation at the endoplasmic reticulum: A new perturbation site for targeted cancer therapy. Cell Res. 2011, 21, 867–883.
12. Princiotta, M.F.; Finzi, D.; Qian, S.B.; Gibbs, J.; Schuchmann, S.; Buttgereit, F.; Bennink, J.R.; Yewdell, J.W. Quantitating protein synthesis, degradation, and endogenous antigen processing Immunity 2003, 18, 343–354
13. Zhong, F.; Yang, D.; Hao, Y.; Lin, C.; Jiang, Y.; Ying, W.; Wu, S.; Zhu, Y.; Liu, S.; Yang, P.; et al. Regular patterns for proteome-wide distribution of protein abundance across species PLoS ONE 2012, 7, e32423
14. Walter, P.; Ron, D. The unfolded protein response: From stress pathway to homeostatic regulation. Science 2011, 334, 1081–1086
15. Chambers, J.E.; Marciniak, S.J. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 2. Protein misfolding and ER stress. Am. J. Physiol. Cell Physiol. 2014, 307, C657–C670
16. Manié, S.N.; Lebeau, J.; Chevet, E. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 3. Orchestrating the unfolded protein response in oncogenesis: An update. Am. J. Physiol. Cell Physiol. 2014, 307, C901–C907
17. Sano, R.; Reed, J.C. ER stress-induced cell death mechanisms. Biochim. Biophys. Acta 2013, 1833, 3460–3470
18. Hinault, M.P.; Ben-Zvi, A.; Goloubinoff, P. Chaperones and proteases: Cellular fold-controlling factors of proteins in neurodegenerative diseases and aging. J. Mol. Neurosci. 2006, 30, 249–265
19. Huang, K. Lectures on Statistical Physics and Protein Folding, 1st ed.; World Scientific: Hackensack, NJ, USA, 2005; pp. 1–100
20. Dobson, M.C. Protein chemistry: In the footsteps of alchemists. Science 2004, 304, 1259–1262
21. Anfinsen, C.B. Principles that govern folding of protein chains. Science 1973, 181, 223–230
22. Dyson, H.J.; Wright, P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol Cell Biol. 2005, 6, 197–208
23. Uversky, V.N.; Dunker, A.K. Understanding protein non-folding. Biochim. Biophys. Acta 2010, 1804, 1231–1264
24. Vuillon, L.; Lesieur, C. From local to global changes in proteins: A network view. Curr. Opin Struct. Biol. 2015, 31, 1–8
25. Nussinov, R.; Tsai, C.J. Allostery in disease and in drug discovery. Cell 2013, 153, 293–305
26. Lipinski, C.; Hopkins, A. Navigating chemical space for biology and medicine. Nature 2004, 432, 855–861
27. Zuiderweg, E.R.; Bertelsen, E.B.; Rousaki, A.; Mayer, M.P.; Gestwicki, J.E.; Ahmad, A Allostery in the Hsp70 chaperone proteins. Top. Curr. Chem. 2013, 328, 99–153
28. Tompa, P. Multisteric regulation by structural disorder in modular signaling proteins: An extension of the concept of allostery. Chem. Rev. 2014, 114, 6715–6732
29. Deshpande, S.; Pfohl, T. Real-time dynamics of emerging actin networks in cell-mimicking compartments. PLoS ONE 2015, 10, e011652
30. Manz, B.N.; Groves, J.T. Spatial organization and signal transduction at intercellular junctions Nat. Rev. Mol. Cell Biol. 2010, 11, 342–352
31. He, X.; Zhang, J. Why do hubs tend to be essential in protein networks? PLoS Genet. 2006, 2, e88.
32. Verdian Doghaei, A.; Housaindokht, M.R.; Bozorgmehr, M.R. Molecular crowding effects on conformation and stability of G-quadruplex DNA structure: Insights from molecular dynamics simulation. J. Theor. Biol.2015, 364, 103–112
33. Karplus, M.; McCammon, A.J. Molecular dynamics simulations of biomolecules. Nat. Struct. Biol 2002, 9, 646–652
34. Mendoza-Espinosa, P.; García-González, V.; Moreno, A.; Castillo, R.; Mas-Oliva, J Disorder-to-order conformational transitions in protein structure and its relationship to disease Mol. Cell. Biochem. 2009, 330, 105–120
35. Bardwell, J.C.; Jakob, U. Conditional disorder in chaperone action. Trends Biochem. Sci. 2012, 37, 517–525
36. Górecki, A.; Bonarek, P.; Górka, A.K.; Figiel, M.; Wilamowski, M.; Dziedzicka-Wasylewska, M Intrinsic disorder of human Yin Yang 1 protein. Proteins 2015, doi:10.1002/prot.24822
37. García-González, V.; Mas-Oliva, J. Amyloidogenic properties of a D/N mutated 12 amino acid fragment of the C-terminal domain of the Cholesteryl-Ester Transfer Protein (CETP). Int. J Mol. Sci. 2011, 12, 2019–2035
38. Guharoy, M.; Pauwels, K.; Tompa, P. SnapShot: Intrinsic structural disorder. Cell 2015, 161, 1230–1230
39. Forman-Kay, J.D.; Mittag, T. From sequence and forces to structure, function, and evolution of intrinsically disordered proteins. Structure 2013, 21, 1492–1499
40. García-González, V.G.; Mas-Oliva, J. El Concepto de Enfermedad Asociado a la Conformación de Proteínas, 1st ed.; Universidad Nacional Autónoma de México and El Manual Moderno: Mexico City, Mexico, 2012; pp. 11–21
41. Dunker, A.K.; Silman, I.; Uversky, V.N.; Sussman, J.L. Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 2008, 18, 756–764
42. Tompa, P.; Fuxreiter, M.; Oldfield, C.J.; Simon, I.; Dunker, A.K.; Uversky, V.N. Close encounters of the third kind: Disordered domains and the interactions of proteins. BioEssays 2009, 31, 328–335
43. Sickmeier, M.; Hamilton, J.A.; LeGall, T.; Vacic, V.; Cortese, M.S.; Tantos, A.; Szabo, B.; Tompa, P.; Chen, J.; Uversky, V.N. et al. DisProt: The database of disordered proteins Nucleic Acids Res. 2007, 35, D786–D793
44. Tantos, A.; Han, K.H.; Tompa, P. Intrinsic disorder in cell signaling and gene transcription Mol. Cell. Endocrinol. 2012, 348, 457–465
45. Hilser, V.J.; Thompson, E.B. Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins. Proc. Natl. Acad. Sci. USA 2007, 104, 8311–8315
46. Ferreon, A.C.; Ferreon, J.C.; Wright, P.E.; Deniz, A.A. Modulation of allostery by protein intrinsic disorder. Nature 2013, 498, 390–394
47. Tompa, P.; Szász, C.; Buday, L. Structural disorder throws new light on moonlighting Trends Biochem. Sci. 2005, 30, 484–489
48. Gould, C.M.; Diella, F.; Via, A.; Puntervoll, P.; Gemünd, C.; Chabanis-Davidson, S.; Michael, S.; Sayadi, A.; Bryne, J.C.; Chica, C. et al. ELM: The status of the 2010 eukaryotic linear motif resource. Nucleic Acids Res. 2010, 38, D167–D180.
49. Stein, A.; Aloy, P. Contextual specificity in peptide-mediated protein interactions. PLoS ONE 2008, 3, e2524
50. Ward, J.J.; Sodhi, J.S.; McGuffin, L.J.; Buxton, B.F.; Jones, D.T. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 2004, 337, 635–645
51. Lobley, A.; Swindells, M.B.; Orengo, C.A.; Jones, D.T. Inferring function using patterns of native disorder in proteins. PLoS Comput. Biol. 2007, 3, e162
52. Dunker, A.K.; Garner, E.; Guilliot, S.; Romero, P.; Albrecht, K.; Hart, J.; Obradovic, Z.; Kissinger, C.; Villafranca, J.E. Protein disorder and the evolution of molecular recognition: Theory, predictions and observations. Pac. Symp. Biocomput. 1998, 473–484
53. Oldfield, C.J.; Meng, J.; Yang, J.Y.; Yang, M.Q.; Uversky, V.N.; Dunker, A.K. Flexible nets: Disorder and induced fit in the associations of p53 and 14-3-3 with their partners. BMC Genomics 2008, 9, S1
54. Andresen, C.; Helander, S.; Lemak, A.; Farès, C.; Csizmok, V.; Carlsson, J.; Penn, L.Z.; Forman-Kay, J.D.; Arrowsmith, C.H.; Lundström, P. et al. Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding. Nucleic Acids Res. 2012, 40, 6353–6266
55. Tompa, P. Intrinsically unstructured proteins. Trends Biochem. Sci. 2002, 27, 527–533
56. James, C.; Tawfik, D.S. Conformational diversity and protein evolution—A 60-year-old hypothesis revisited. Trends Biochem. Sci. 2003, 28, 361–368
57. Bustos, D.M.; Iglesias, A.A. Intrinsic disorder is a key characteristic in partners that bind 14-3-3 proteins. Proteins 2006, 63, 35–42
58. Kriwacki, R.W.; Hengst, L.; Tennant, L.; Reed, S.I.; Wright, P.E. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: Conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA1996, 93, 11504–11509
59. Dalal, S.; Regan, L. Understanding the sequence determinants of conformational switching using protein design. Protein Sci. 2000, 9, 1651–1659
60. Cheng, Y.; LeGall, T.; Oldfield, C.J.; Mueller, J.P.; Van, Y.Y.; Romero, P.; Cortese, M.S.; Uversky, V.N.; Dunker, A.K. Rational drug design via intrinsically disordered protein Trends Biotechnol. 2006, 2, 435–442
61. Chandra, S.; Chen, X.; Rizo, J.; Jahn, R.; Sudhof, T.C. A broken α-helix in folded α-synuclein J. Biol. Chem. 2003, 278, 15313–15318
62. Fink, A.L. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold. Des 1998, 3, R9–R23
63. Eisenberg, D.; Jucker, M. The amyloid state of proteins in human diseases. Cell 2012, 148, 1188–1203
64. Meredith, S.C. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins. Ann. N. Y. Acad. Sci. 2005, 1066, 181–221
65. Chiti, F.; Dobson, C.M. Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 2006, 75, 333–366
66. Dobson, C.M. Protein folding and misfolding. Nature 2003, 426, 884–890.
67. Sawaya, M.R.; Sambashivan, S.; Nelson, R.; Ivanova, M.I.; Sievers, S.A.; Apostol, M.I.; Thompson, M.J.; Balbirnie, M.; Wiltzius, J.J.; McFarlane, H.T. et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 2007, 447, 453–457
68. Fitzpatrick, A.W.P.; Debelouchina, G.T.; Bayro, M.J.; Clare, D.K.; Caporini, M.A.; Bajaj, V.S.; Jaroniec, C.P.; Wang, L.; Ladizhansky, V.; Müller, S.A. Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proc. Natl Acad. Sci. USA 2013, 110, 5468–5473
69. Knowles, T.P.; Fitzpatrick, A.W.; Meehan, S.; Mott, H.R.; Vendruscolo, M.; Dobson, C.M.; Welland, M.E. Role of intermolecular forces in defining material properties of protein nanofibrils. Science 2007, 318, 1900–1903
70. De Genst, E.; Chirgadze, D.Y.; Klein, F.A.; Butler, D.C.; Matak-Vinković, D.; Trottier, Y.; Huston, J.S.; Messer, A.; Dobson, C.M. Structure of a single-chain fv bound to the 17 N-terminal residues of huntingtin provides insights into pathogenic amyloid formation and suppression J. Mol. Biol.2015, 427, 2166–2178
71. Greenwald, J.; Riek, R. On the possible amyloid origin of protein folds. J. Mol. Biol. 2012, 421, 417–426
72. Carny, O.; Gazit, E. A model for the role of short self-assembled peptides in the very early stages of the origin of life. FASEB J. 2005, 19, 1051–1055
73. Fowler, D.M.; Koulov, A.V.; Balch, W.E.; Kelly, J.W. Functional amyloid—From bacteria to humans. Trends Biochem. Sci. 2007, 32, 217–224
74. Fandrich, M.; Dobson, C.M. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 2002, 21, 5682–5690
75. Chapman, M.R.; Robinson, L.S.; Pinkner, J.S.; Roth, R.; Heuser, J.; Hammar, M.; Normark, S.; Hultgren, S.J. Role of Escherichia coli curli operons in directing amyloid fiber formation Science 2002, 295, 851–855
76. Claessen, D.; Rink, R.; de Jong, W.; Siebring, J.; de Vreugd, P.; Boersma, F.G.; Dijkhuizen, L.; Wosten, H.A. A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils. Genes Dev. 2003, 17, 1714–1726
77. Mackay, J.P.; Matthews, J.M.; Winefield, R.D.; Mackay, L.G.; Haverkamp, R.G.; Templeton, M.D The hydrophobin EAS is largely unstructured in solution and functions by forming amyloid-like structures. Structure 2001, 9, 83–91
78. Coustou, V.; Deleu, C.; Saupe, S.; Begueret, J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl Acad. Sci. USA 1997, 94, 9773–9778
79. King, C.Y.; Tittmann, P.; Gross, H.; Gebert, R.; Aebi, M.; Wüthrich, K. Prion-inducing domain 2–114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl. Acad Sci. USA 1997, 94, 6618–6622
80. Iconomidou, V.A.; Vriend, G.; Hamodrakas, S.J. Amyloids protect the silkmoth oocyte and embryo. FEBS Lett. 2000, 479, 141–145.
81. Iconomidou, V.A.; Chryssikos, G.D.; Gionis, V.; Galanis, A.S.; Cordopatis, P.; Hoenger, A.; Hamodrakas, S.J. Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family J. Struct. Biol.2006, 156, 480–488
82. Berson, J.F.; Theos, A.C.; Harper, D.C.; Tenza, D.; Raposo, G.; Marks, M.S. Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J. Cell Biol.2003, 161, 521–533
83. Kobayashi, T.; Urabe, K.; Orlow, S.J.; Higashi, K.; Imokawa, G.; Kwon, B.S.; Potterf, B.; Hearing, V.J. The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function. J. Biol. Chem.1994, 269, 29198–29205
84. Stefani, M.; Dobson, C.M. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 2003, 81, 678–699
85. García-González, V.; Mas-Oliva, J. Amyloid fibril formation of peptides derived from the C-terminus of CETP modulated by lipids. Biochem. Biophys. Res. Commun. 2013, 434, 54–59
86. Fernandez-Escamilla, A.M.; Rousseau, F.; Schymkowitz, J.; Serrano, L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins Nat. Biotechnol. 2004, 22, 1302–1306
87. Pawar, A.P.; Dubay, K.F.; Zurdo, J.; Chiti, F.; Vendruscolo, M.; Dobson, C.M. Prediction of “aggregation-prone” and “aggregation-susceptible” regions in proteins associated with neurodegenerative diseases. J. Mol. Biol.2005, 350, 379–392
88. Matzinger, P. Friendly and dangerous signals: Is the tissue in control? Nat. Immunol.2007, 8, 11–13
89. Balch, W.E.; Morimoto, R.I.; Dillin, A.; Kelly, J.W. Adapting proteostasis for disease intervention Science 2008, 319, 916–919
90. Kim, Y.E.; Hipp, M.S.; Bracher, A.; Hayer-Hartl, M.; Hartl, F.U. Molecular chaperone functions in protein folding and proteostasis. Annu. Rev. Biochem. 2013, 82, 323–355
91. Vendruscolo, M.; Knowles, T.P.J.; Dobson, C.M. Protein solubility and protein homeostasis: A generic view of protein misfolding disorders. Cold Spring Harb. Perspect. Biol. 2011, 3, a010454
92. Knowles, T.P.; Vendruscolo, M.; Dobson, C.M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 2014, 15, 384–396
93. Calloni, G.; Chen, T.; Schermann, S.M.; Chang, H.-C.; Genevaux, P.; Agostini, F.; Tartaglia, G.G.; Hayer-Hartl, M.; Hartl, F.U. DnaK functions as a central hub in the E. coli chaperone network Cell Rep. 2012, 1, 251–264
94. Willmund, F.; del Alamo, M.; Pechmann, S.; Chen, T.; Albanese, V.; Dammer, E.B.; Peng, J.; Frydman, J. The cotranslational function of ribosome-associated Hsp70 in eukaryotic protein homeostasis. Cell 2013, 152, 196–209
95. Gershenson, A.; Gierasch, L.M. Protein folding in the cell: Challenges and progress. Curr. Opin Struct. Biol. 2011, 21, 32–41
96. Hartl, F.U.; Bracher, A.; Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 2011, 475, 324–332
97. Asherie, N. Protein crystallization and phase diagrams. Methods 2004, 34, 266–272.
98. Finka, A.; Goloubinoff, P. Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasis. Cell Stress Chaperones 2013, 18, 591–605
99. Reichmann, D.; Xu, Y.; Cremers, C.M.; Ilbert, M.; Mittelman, R.; Fitzgerald, M.C.; Jakob, U Order out of disorder: Working cycle of an intrinsically unfolded chaperone. Cell 2012, 148, 947–957
100. Rosenbaum, J.C.; Fredrickson, E.K.; Oeser, M.L.; Garrett-Engele, C.M.; Locke, M.N.; Richardson, L.A.; Nelson, Z.W.; Hetrick, E.D.; Milac, T.I.; Gottschling, D.E. et al. Disorder targets misorder in nuclear quality control degradation: A disordered ubiquitin ligase directly recognizes its misfolded substrates. Mol. Cell 2011, 41, 93–106
101. Mayer, M.P. Gymnastics of molecular chaperones. Mol. Cell 2010, 39, 321–331
102. Ellis, R.J. Molecular chaperones: Assisting assembly in addition to folding. Trends Biochem. Sci 2006, 31, 395–401
103. Saibil, H.R. Chaperone machines in action. Curr. Opin. Struct. Biol. 2008, 18, 35–42
104. Wandinger, S.K.; Richter, K.; Buchner, J. The Hsp90 chaperone machinery. J. Biol. Chem. 2008, 283, 18473–18477
105. Tokuriki, N.; Tawfik, D.S. Chaperonin overexpression promotes genetic variation and enzyme evolution. Nature 2009, 459, 668–671
106. Rutherford, S.L.; Lindquist, S. Hsp90 as a capacitor for morphological evolution. Nature 1998, 396, 336–342
107. Slepenkov, S.V.; Witt, S.N. The unfolding story of the Escherichia coli Hsp70 DnaK: Is DnaK a holdase or an unfoldase? Mol. Microbiol.2002, 45, 1197–1206
108. Bosl, B.; Grimminger, V.; Walter, S. The molecular chaperone Hsp104—A molecular machine for protein disaggregation. J. Struct. Biol. 2006, 156, 139–148
109. Langer, T.; Lu, C.; Echols, H.; Flanagan, J.; Hayer, M.K.; Hartl, F.U. Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding. Nature 1992, 356, 683–689
110. Horwich, A.L.; Fenton, W.A. Chaperonin-mediated protein folding: Using a central cavity to kinetically assist polypeptide chain folding. Q. Rev. Biophys.2009, 42, 83–116
111. Taldone, T.; Patel, H.J.; Bolaender, A.; Patel, M.R.; Chiosis, G. Protein chaperones: A composition of matter review (2008–2013). Expert Opin. Ther. Pat. 2014, 24, 501–518
112. Yan, M.; Li, J.; Sha, B. Structural analysis of the Sil1-Bip complex reveals the mechanism for Sil1 to function as a nucleotide-exchange factor. Biochem. J. 2011, 438, 447–455
113. Morimoto, R.I. The heat shock response: Systems biology of proteotoxic stress in aging and disease. Cold Spring Harb. Symp. Quant. Biol. 2011, 76, 91–99
114. Vabulas, R.M.; Raychaudhuri, S.; Hayer-Hartl, M.; Hartl, F.U. Protein folding in the cytoplasm and the heat shock response. Cold Spring Harb. Perspect. Biol. 2010, 2, a004390
115. Westerheide, S.D.; Anckar, J.; Stevens, S.M., Jr.; Sistonen, L.; Morimoto, R.I. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 2009, 323, 1063–1066
116. Kovacs, D.; Tompa, P. Diverse functional manifestations of intrinsic structural disorder in molecular chaperones. Biochem. Soc. Trans. 2012, 40, 963–968
117. Snapp, E.L. Unfolded protein responses with or without unfolded proteins? Cells 2012, 1, 926–950.
118. Carrara, M.; Prischi, F.; Nowak, P.R.; Kopp, M.C.; Ali, M.M. Noncanonical binding of BiP ATPase domain to Ire1 and Perk is dissociated by unfolded protein CH1 to initiate ER stress signaling. Elife 2015, 4, doi:10.7554/eLife.03522
119. Foit, L.; George, J.S.; Zhang, B.W.; Brooks, C.L.,; Bardwell, J.C. Chaperone activation by unfolding. Proc. Natl. Acad. Sci. USA 2013, 110, E1254–E1262
120. Ozcan, L.; Tabas, I. Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annu. Rev. Med. 2012, 63, 317–328
121. Ellgaard, L.; Helenius, A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol 2003, 4, 181–191
122. Korennykh, A.; Walter, P. Structural basis of the unfolded protein response. Annu. Rev. Cell Dev. Biol. 2012, 28, 251–277
123. Zhou, J.; Liu, C.Y.; Back, S.H.; Clark, R.L.; Peisach, D.; Xu, Z.; Kaufman, R.J. The crystal structure of human IRE1 luminal domain reveals a conserved dimerization interface required for activation of the unfolded protein response. Proc. Natl. Acad. Sci. USA 2006, 103, 14343–14348
124. Smith, M.H.; Ploegh, H.L.; Weissman, J.S. Road to ruin: Targeting proteins for degradation in the endoplasmic reticulum. Science 2011, 334, 1086–1090
125. Voeltz, G.K.; Rolls, M.M.; Rapoport, T.A. Structural organization of the endoplasmic reticulum EMBO Rep. 2002, 3, 944–950
126. Schindler, A.J.; Schekman, R. In vitro reconstitution of ER-stress induced ATF6 transport in COPII vesicles. Proc. Natl. Acad. Sci. USA 2009, 106, 17775–17780
127. Haze, K.; Yoshida, H.; Yanagi, H.; Yura, T.; Mori, K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell 1999, 10, 3787–3799
128. Ye, J.; Rawson, R.B.; Komuro, R.; Chen, X.; Davé, U.P.; Prywes, R.; Brown, M.S.; Goldstein, J.L ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs Mol. Cell 2000, 6, 1355–1364
129. Marciniak, S.J.; Yun, C.Y.; Oyadomari, S.; Novoa, I.; Zhang, Y.; Jungreis, R.; Nagata, K.; Harding, H.P.; Ron, D. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004, 18, 3066–3077
130. Tsaytler, P.; Harding, H.P.; Ron, D.; Bertolotti, A. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 2011, 332, 91–94
131. Calfon, M.; Zeng, H.; Urano, F.; Till, J.H.; Hubbard, S.R.; Harding, H.P.; Clark, S.G.; Ron, D IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA Nature 2002, 415, 92–96
132. Yoshida, H.; Matsui, T.; Yamamoto, A.; Okada, T.; Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001, 107, 881–891
133. Shen, X.; Ellis, R.E.; Lee, K.; Liu, C.Y.; Yang, K.; Solomon, A.; Yoshida, H.; Morimoto, R.; Kurnit, D.M.; Mori, K. et al. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 2001, 107, 893–903.
134. Lee, K.; Tirasophon, W.; Shen, X.; Michalak, M.; Prywes, R.; Okada, T.; Yoshida, H.; Mori, K.; Kaufman, R.J. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 2002, 16, 452–466
135. Yoshida, H.; Matsui, T.; Hosokawa, N.; Kaufman, R.J.; Nagata, K.; Mori, K. A time-dependent phase shift in the mammalian unfolded protein response. Dev. Cell 2003, 4, 265–271
136. Reimold, A.M.; Iwakoshi, N.N.; Manis, J.; Vallabhajosyula, P.; Szomolanyi-Tsuda, E.; Gravallese, E.M.; Friend, D.; Grusby, M.J.; Alt, F.; Glimcher, L.H. Plasma cell differentiation requires the transcription factor XBP-1. Nature 2001, 412, 300–307
137. Korennykh, A.V.; Egea, P.F.; Korostelev, A.A.; Finer-Moore, J.; Stroud, R.M.; Zhang, C.; Shokat, K.M.; Walter, P. Cofactor-mediated conformational control in the bifunctional kinase/RNase Ire1. BMC Biol. 2011, 9, 48
138. Brewer, J.W. Regulatory crosstalk within the mammalian unfolded protein response. Cell Mol Life Sci. 2014, 71, 1067–1079
139. Hetz, C. The unfolded protein response: Controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 2012, 13, 89–102
140. Lin, J.H.; Li, H.; Yasumura, D.; Cohen, H.R.; Zhang, C.; Panning, B.; Shokat, K.M.; Lavail, M.M.; Walter, P. IRE1 signaling affects cell fate during the unfolded protein response Science 2007, 318, 944–949
141. Li, H.; Korennykh, A.V.; Behrman, S.L.; Walter, P. Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering. Proc. Natl. Acad. Sci. USA 2010, 107, 16113–16118
142. Escusa-Toret S.; Vonk, W.I.; Frydman, J. Spatial sequestration of misfolded proteins by a dynamic chaperone pathway enhances cellular fitness during stress. Nat. Cell Biol. 2013, 15, 1231–1243
143. Duttler, S.; Pechmann, S.; Frydman, J. Principles of cotranslational ubiquitination and quality control at the ribosome. Mol. Cell 2013, 50, 379–393
144. Wang, F.; Durfee, L.A.; Huibregtse, J.M. A cotranslational ubiquitination pathway for quality control of misfolded proteins. Mol. Cell 2013, 50, 368–378
145. Pechmann, S.; Chartron, J.W.; Frydman, J. Local slowdown of translation by nonoptimal codons promotes nascent-chain recognition by SRP in vivo. Nat. Struct. Mol. Biol. 2014, 21, 1100–1105
146. Wolff, S.; Weissman, J.S.; Dillin, A. Differential scales of protein quality control. Cell 2014, 157, 52–64
147. Douglas, P.M.; Summers, D.W.; Cyr, D.M. Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways. Prion 2009, 3, 51–58
148. Cohen, E.; Bieschke, J.; Perciavalle, R.M.; Kelly, J.W.; Dillin, A. Opposing activities protect against age-onset proteotoxicity. Science 2006, 313, 1604–1610
149. Arrasate, M.; Mitra, S.; Schweitzer, E.S.; Segal, M.R.; Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431, 805–810
150. Kaganovich, D.; Kopito, R.; Frydman, J. Misfolded proteins partition between two distinct quality control compartments. Nature 2008, 454, 1088–1095.
151. Ogrodnik, M.; Salmonowicz, H.; Brown, R.; Turkowska, J.; Średniawa, W.; Pattabiraman, S.; Amen, T.; Abraham, A.C.; Eichler, N.; Lyakhovetsky, R. et al. Dynamic JUNQ inclusion bodies are asymmetrically inherited in mammalian cell lines through the asymmetric partitioning of vimentin. Proc. Natl. Acad. Sci. USA 2014, 11, 8049–8054
152. Polling, S.; Mok, Y.F.; Ramdzan, Y.M.; Turner, B.J.; Yerbury, J.J.; Hill, A.F.; Hatters, D.M Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell. J. Biol. Chem. 2014, 289, 6669–6690
153. Weisberg, S.J.; Lyakhovetsky, R.; Werdiger, A.-C.; Gitler, A.D.; Soen, Y.; Kaganovich, D Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity. Proc. Natl. Acad. Sci. USA 2012, 109, 15811–15816
154. Cohen, S.I.; Arosio, P.; Presto, J.; Kurudenkandy, F.R.; Biverstål, H.; Dolfe, L.; Dunning, C.; Yang, X.; Frohm, B.; Vendruscolo, M. et al. A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers. Nat. Struct. Mol. Biol. 2015, 22, 207–213
155. Wrighton, K.H. Protein folding: Misfolded proteins join the Q. Nat. Rev. Mol. Cell Biol. 2013, 14, 608
156. Labbadia, J.; Morimoto, R.I. The biology of proteostasis in aging and disease. Annu. Rev. Biochem2015, doi:10.1146/annurev-biochem-060614-033955
157. Voisine, C.; Pedersen, J.S.; Morimoto, R.I. Chaperone networks: Tipping the balance in protein folding diseases. Neurobiol. Dis. 2010, 40, 12–20
158. Fredrickson, E.K.; Gardner, R.G. Selective destruction of abnormal proteins by ubiquitin-mediated protein quality control degradation. Semin. Cell Dev. Biol. 2012, 23, 530–537
159. He, C.; Klionsky, D.J. Regulation mechanisms and signaling pathways of autophagy Annu. Rev. Genet. 2009, 43, 67–93
160. Schmidt, M.; Finley, D. Regulation of proteasome activity in health and disease Biochim. Biophys. Acta 2014, 1843, 13–25
161. Murata, S.; Yashiroda, H.; Tanaka, K. Molecular mechanisms of proteasome assembly. Nat. Rev Mol. Cell Biol. 2009, 10, 104–115
162. Kusmierczyk, A.R.; Kunjappu, M.J.; Funakoshi, M.; Hochstrasser, M. A multimeric assembly factor controls the formation of alternative 20S proteasomes. Nat. Struct. Mol. Biol. 2008, 15, 237–244
163. Konstantinova, I.M.; Tsimokha, A.S.; Mittenberg, A.G.; Kwang, W.J. Role of proteasomes in cellular regulation. In International Review of Cell and Molecular Biology; Academic Press: San Diego, CA, USA, 2008; Volume 267, pp. 59–124
164. Da Fonseca, P.C.A.; He, J.; Morris, E.P. Molecular model of the human 26S proteasome Mol. Cell 2012, 46, 54–66
165. Rosenzweig, R.; Osmulski, P.A.; Gaczynska, M.; Glickman, M.H. The central unit within the 19S regulatory particle of the proteasome. Nat. Struct. Mol. Biol. 2008, 15, 573–580
166. Kikuchi, J.; Iwafune, Y.; Akiyama, T.; Okayama, A.; Nakamura, H.; Arakawa, N.; Kimura, Y.; Hirano, H. Co- and post-translational modifications of the 26S proteasome in yeast. Proteomics 2010, 10, 2769–2779
167. Tanaka, K. The proteasome: Overview of structure and functions. Proc. Jpn. Acad. Ser. B 2009, 85, 12–36.
168. Li, X.; Demartino, G.N. Variably modulated gating of the 26S proteasome by ATP and polyubiquitin. Biochem. J. 2009, 421, 397–404
169. Sledź, P.; Förster, F.; Baumeister, W.J. Allosteric effects in the regulation of 26S proteasome activities. Mol. Biol. 2013, 425, 1415–1423
170. Price, J.L.; Davis, P.B.; Morris, J.C.; White, D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol. Aging 1991, 12, 295–312
171. Masters, C.L.; Simms, G.; Weinman, N.A.; Multhaup, G.; McDonald, B.L.; Beyreuther, K Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad Sci. USA 198, 82, 4245–4259
172. Gregori, L.; Hainfeld, J.F.; Simon, M.N.; Goldgaber, D. Binding of amyloid β protein to the 20 S proteasome. J. Biol. Chem.1997, 272, 58–62
173. Gregori, L.; Fuchs, C.; Figueiredo-Pereira, M.E.; van Nostrand, W.E.; Goldgaber, D. Amyloid β-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem.1995, 270, 19702–19708
174. Lopez Salon, M.; Pasquini, L.; Besio Moreno, M.; Pasquini, J.M.; Soto, E. Relationship between β-amyloid degradation and the 26S proteasome in neural cells. Exp. Neurol. 2003, 180, 131–143
175. Oh, S.; Hong, H.S.; Hwang, E.; Sim, H.J.; Lee, W.; Shin, S.J.; Mook-Jung, I. Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech. Ageing Dev. 2005, 126, 1292–1299
176. Choi, A.M.; Ryter, S.W.; Levine, B. Autophagy in human health and disease. N. Engl. J. Med 2013, 368, 651–662
177. Wang, Z.V.; Hill, J.A. Protein quality control and metabolism: Bidirectional control in the heart Cell Metab. 2015, 21, 215–226
178. Reggiori, F.; Klionsky, D.J. Autophagic processes in yeast: Mechanism, machinery and regulation. Genetics 2013, 194, 341–361
179. Noda, N.N.; Inagaki, F. Mechanisms of autophagy. Annu. Rev. Biophys. 2015, doi:10.1146/ annurev-biophys-060414-034248
180. Cuervo, A.M.; Wong, E. Chaperone-mediated autophagy: Roles in disease and aging. Cell Res2014, 24, 92–104
181. Yang, Z.; Klionsky, D.J. Mammalian autophagy: Core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 2010, 22, 124–131
182. Kroemer, G.; Mariño, G.; Levine, B. Autophagy and the integrated stress response. Mol. Cell 2010, 40, 280–293
183. Levine, B.; Kroemer, G. Autophagy in the pathogenesis of disease. Cell 2008, 132, 27–42
184. Yu, W.H.; Cuervo, A.M.; Kumar, A.; Peterhoff, C.M.; Schmidt, S.D.; Lee, J.H.; Mohan, P.S.; Mercken, M.; Farmery, M.R.; Tjernberg, L.O. et al. Macroautophagy a novel β-amyloid peptide-generating pathway activated in Alzheimer’s disease. J. Cell Biol.2005, 171, 87–98
185. Rubinsztein, D.C.; Gestwicki, J.E.; Murphy, L.O.; Klionsky, D.J. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 2007, 6, 304–312
186. Ferraro, E.; Cecconi, F. Autophagic and apoptotic response to stress signals in mammalian cells Arch. Biochem. Biophys. 2007, 462, 210–219.
187. Gavrin, L.K.; Denny, R.A.; Saiah, E. Small molecules that target protein misfolding. J. Med. Chem 2012, 55, 10823–10843
188. Ciryam, P.; Tartaglia, G.G.; Morimoto, R.I.; Dobson, C.M.; Vendruscolo, M. Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep 2013, 5, 781–790
189. Brocchieri, L.; Karlin, S. Protein length in eukaryotic and prokaryotic proteomes. Nucleic Acids Res 2005, 33, 3390–3400
190. Ogle, J.M.; Ramakrishnan, V. Structural insights into translational fidelity. Annu. Rev. Biochem 2005, 74, 129–177
191. Pechmann, S.; Willmund, F.; Frydman, J. The ribosome as a hub for protein quality control Mol. Cell 2013, 49, 411–421
192. Huang, C.J.; Lin, C.Y.; Haataja, L.; Gurlo, T.; Butler, A.E.; Rizza, R.A.; Butler, P.C. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes Diabetes 2007, 56, 2016–2027
193. Han, J.; Back, S.H.; Hur, J.; Lin, Y.H.; Gildersleeve, R.; Shan, J.; Yuan, C.L.; Krokowski, D.; Wang, S.; Hatzoglou, M. et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol. 2013, 15, 481–490
194. Tyedmers, J.; Mogk, A.; Bukau, B. Cellular strategies for controlling protein aggregation Nat. Rev. Mol. Cell Biol. 2010, 11, 777–788
195. Bence, N.F.; Sampat, R.M.; Kopito, R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001, 292, 1552–1555
196. Ross, C.A.; Poirier, M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10, S10–S17
197. Glickman, M.H.; Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol. Rev.2002, 82, 373–428
198. Rubinsztein, D.C. The roles of intracellular protein-degradation pathways in neurodegeneration Nature 2006, 443, 780–786
199. Mizushima, N.; Levine, B.; Cuervo, A.M.; Klionsky, D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451, 1069–1075
200. Knowles, T.P.J.; Shu, W.; Devlin, G.L.; Meehan, S.; Auer, S.; Dobson, C.M.; Welland, M.E Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass. Proc. Natl. Acad. Sci. USA2007, 104, 10016–10021
201. Xu, L.Q.; Wu, S.; Buell, A.K.; Cohen, S.I.; Chen, L.J.; Hu, W.H.; Cusack, S.A.; Itzhaki, L.S.; Zhang, H.; Knowles, T.P. et al. Influence of specific Hsp70 domains on fibril formation of the yeast prion protein Ure2. Philos. Trans. R. Soc. B 2013, 368, 20110410
202. Lee, J.; Ozcan, U. Unfolded protein response signaling and metabolic diseases. J. Biol. Chem 2014, 289, 1203–1211
203. Huang, A.; Stultz, C.M. Finding order within disorder: Elucidating the structure of proteins associated with neurodegenerative disease. Future Med. Chem.2009, 1, 467–482
204. Cnop, M.; Igoillo-Esteve, M.; Cunha, D.A.; Ladrière, L.; Eizirik, D.L. An update on lipotoxic endoplasmic reticulum stress in pancreatic β-cells. Biochem. Soc. Trans. 2008, 36, 909–915.
205. Hetz, C.; Mollereau, B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 2014, 15, 233–249
206. Steiner, H.; Haass, C. Intramembrane proteolysis by presenilins. Nat. Rev. Mol. Cell Biol. 2000, 1, 217–224
207. Van Laar, V.S.; Arnold, B.; Cassady, S.J.; Chu, C.T.; Burton, E.A.; Berman, S.B.; Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization. Hum. Mol. Genet. 2011, 20, 927–940
208. Cao, S.S.; Kaufman, R.J. Targeting endoplasmic reticulum stress in metabolic disease. Expert Opin Ther. Targets 2012, 17, 437–448
209. Hotamisligil, G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 2010, 140, 900–917
210. Cao, P.; Abedini, A.; Raleigh, D.P. Aggregation of islet amyloid polypeptide: From physical chemistry to cell biology. Curr. Opin. Struct. Biol. 2013, 23, 82–89
211. Fernández, M.S. Human IAPP amyloidogenic properties and pancreatic β-cell death. Cell Calcium 2014, 56, 416–427
212. Casas, S.; Gomis, R.; Gribble, F.M.; Altirriba, J.; Knuutila, S.; Novials, A. Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic β-cell apoptosis Diabetes 2007, 56, 2284–2294
213. Costes, S.; Huang, C.J.; Gurlo, T.; Daval, M.; Matveyenko, A.V.; Rizza, R.A.; Butler, A.E.; Butler, P.C. β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency. Diabetes 2011, 60, 227–238
214. Ozcan, U.; Cao, Q.; Yilmaz, E.; Lee, A.H.; Iwakoshi, N.N.; Ozdelen, E.; Tuncman, G.; Görgün, C.; Glimcher, L.H.; Hotamisligil, G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306, 457–461
215. Welters, H.J.; Tadayyon, M.; Scarpello, J.H.; Smith, S.A.; Morgan, N.G. Mono-unsaturated fatty acids protect against β-cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure. FEBS Lett. 2004, 560, 103–108
216. Díaz-Villanueva, J.F.; García-González, V. Key interactions in the binding of free fatty acids on amylin-structure transitions. 2015, manuscript in preparation
217. Tabas, I. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ. Res 2010, 107, 839–850
218. Kaufman, R.J. Orchestrating the unfolded protein response in health and disease. J. Clin. Investig2002, 110, 1389–1398
219. Han, D.; Lerner, A.G.; Vande, W.L.; Upton, J.P.; Xu, W.; Hagen, A.; Backes, B.J.; Oakes, S.A.; Papa, F.R. IRE1α kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell 2009, 138, 562–575
220. Blais, J.D.; Chin, K.T.; Zito, E.; Zhang, Y.; Heldman, N.; Harding, H.P.; Fass, D.; Thorpe, C.; Ron, D.A. Small molecule inhibitor of endoplasmic reticulum oxidation 1 (ERO1) with selectively reversible thiol reactivity. J. Biol. Chem. 2010, 285, 20993–21003
221. Ma, Y.; Hendershot, L.M. The role of the unfolded protein response in tumour development: Friend or foe? Nat. Rev. Cancer 2004, 4, 966–977.
222. Moenner, M.; Pluquet, O.; Bouchecareilh, M.; Chevet, E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 2007, 67, 10631–10634
223. Rouschop, K.M.; van den Beucken, T.; Dubois, L.; Niessen, H.; Bussink, J.; Savelkouls, K.; Keulers, T.; Mujcic, H.; Landuyt, W.; Voncken, J.W. et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Investig. 2010, 120, 127–141
224. Blais, J.D.; Addison, C.L.; Edge, R.; Falls, T.; Zhao, H.; Wary, K.; Koumenis, C.; Harding, H.P.; Ron, D.; Holcik, M. et al. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol. Cell. Biol.2006, 26, 9517–9532
225. Spiotto, M.T.; Banh, A.; Papandreou, I.; Cao, H.; Galvez, M.G.; Gurtner, G.C.; Denko, N.C.; Le, Q.T.; Koong, A.C. Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth. Cancer Res. 2010, 70, 78–88
226. Lee, A.S. GRP78 induction in cancer: Therapeutic and prognostic implications. Cancer Res 2007, 67, 3496–3499
227. Pyrko, P.; Schonthal, A.H.; Hofman, F.M.; Chen, T.C.; Lee, A.S. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas Cancer Res. 2007, 67, 9809–9816
228. Chen, T.C. GRP78/BiP modulation of GRP78/BiP in altering sensitivity to chemotherapy Methods Enzymol. 2011, 491, 25–36
229. Li, X.; Zhang, K.; Li, Z. Unfolded protein response in cancer: The physician’s perspective J. Hematol. Oncol. 2011, 4, 8
230. Park, H.R.; Tomida, A.; Sato, S.; Tsukumo, Y.; Yun, J.; Yamori, T.; Hayakawa, Y.; Tsuruo, T.; Shin-ya, K. Effect on tumor cells of blocking survival response to glucose deprivation. J. Natl Cancer Inst. 2004, 96, 1300–1310
231. Saito, S.; Furuno, A.; Sakurai, J.; Sakamoto, A.; Park, H.R.; Shin-Ya, K.; Tsuruo, T.; Tomida, A Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation. Cancer Res. 2009, 69, 4225–4234
232. Backer, J.M.; Krivoshein, A.V.; Hamby, C.V.; Pizzonia, J.; Gilbert, K.S.; Ray, Y.S.; Brand, H.; Paton, A.W.; Paton, J.C.; Backer, M.V. Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells. Neoplasia 2009, 11, 1165–1173
233. Brown, C.J.; Lain, S.; Verma, C.S.; Fersht, A.R.; Lane, D.P. Awakening guardian angels: Drugging the p53 pathway. Nat. Rev. Cancer 2009, 12, 862–873
234. Olivier, M.; Hollstein, M.; Hainaut, P. TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2010, 1, a001008
235. Cho, Y.; Gorina, S.; Jeffrey, P.D.; Pavletich, N.P. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 1994, 265, 346–355
236. Segalat, L. Loss-of-function genetic diseases and the concept of pharmaceutical targets Orphanet. J. Rare Dis. 2007, 2, 30–36
237. Rippin, T.M.; Bykov, V.J.; Freund, S.M.; Selivanova, G.; Wiman, K.G.; Fersht, A.R Characterization of the p53-rescue drug CP-31398 in vitro and in living cells. Oncogene 2002, 21, 2119–2129.
238. Friedler, A.; Hansson, L.O.; Veprintsev, D.B.; Freund, S.M.; Rippin, T.M.; Nikolova, P.V.; Proctor, M.R.; Rüdiger, S.; Fersht, A.R. A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants. Proc. Natl. Acad. Sci. USA 2002, 99, 937–942
239. Ellis, R.J. Macromolecular crowding: An important but neglected aspect of the intracellular environment. Curr. Opin. Struct. Biol. 2001, 11, 114–119
240. Gribbin, J.R. Deep Simplicity: Bringing Order to Chaos and Complexity, 1st ed.; Random House Inc.: New York, NY., USA, 2004; pp. 1–304
241. Baigent, C.; Keech, A.; Kearney, P.M.; Blackwell, L.; Buck, G.; Pollicino, C.; Kirby, A.; Sourjina, T.; Peto, R.; Collins, R. et al. Efficacy and safety of cholesterol lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 2005, 366, 1267–1278
242. Perutz, M.F.; Pope, B.J.; Owen, D.; Wanker, E.E.; Scherzinger, E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques. Proc. Natl. Acad. Sci. USA 2002, 99, 5596–5600
243. Guijarro, J.I.; Sunde, M.; Jones, J.A.; Campbell, I.D.; Dobson. C.M. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. USA 1998, 95, 4224–4228
244. Wasmer, C.; Schütz, A.; Loquet, A.; Buhtz, C.; Greenwald, J.; Riek, R.; Böckmann, A.; Meier, B.H The molecular organization of the fungal prion HET-s in its amyloid form. J. Mol. Biol. 2009, 394, 119–127
245. Johnson, S.M.; Wiseman, R.L.; Sekijima, Y.; Green, N.S.; Adamski-Werner, S.L.; Kelly, J.W Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses. Acc. Chem. Res.2005, 38, 911–921
246. Lansbury, P. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease? Proc. Natl. Acad. Sci. USA 1999, 96, 3342–3344
247. Hetz, C.; Chevet, E.; Harding, H.P. Targeting the unfolded protein response in disease. Nat. Rev Drug Discov. 2013, 12, 703–719
248. Kraskiewicz, H.; FitzGerald, U. InterfERing with endoplasmic reticulum stress. Trends Pharmacol. Sci2012, 33, 53–63
249. Lindquist, S.L.; Kelly, J.W. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: Progress and prognosis. Cold Spring Harb. Perspect. Biol. 2011, 3, a004507
250. Ozcan, U.; Yilmaz, E.; Ozcan, L.; Furuhashi, M.; Vaillancourt, E.; Smith, R.O.; Görgün, C.Z.; Hotamisligil, G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313, 1137–1140
251. Ozcan, L.; Ergin, A.S.; Lu, A.; Chung, J.; Sarkar, S.; Nie, D.; Myers, M.G.,; Ozcan, U Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 2009, 9, 35–51
252. Xiao, C.; Giacca, A.; Lewis, G.F. Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and β-cell dysfunction in humans. Diabetes 2011, 60, 918–924.
253. Kars, M.; Yang, L.; Gregor, M.F.; Mohammed, B.S.; Pietka, T.A.; Finck, B.N.; Patterson, B.W.; Horton, J.D.; Mittendorfer, B.; Hotamisligil, G.S. et al. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women Diabetes2010, 59, 1899–1905
254. Promlek, T.; Ishiwata-Kimata, Y.; Shido, M.; Sakuramoto, M.; Kohno, K.; Kimata, YMembrane aberrancy and unfolded proteins activate the endoplasmic reticulum stress sensor Ire1 in different ways. Mol. Biol. Cell2011, 22, 3520–3532
255. Wiseman, R.L.; Zhang, Y.; Lee, K.P.; Harding, H.P.; Haynes, C.M.; Price, J.; Sicheri, F.; Ron, D. Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1. Mol. Cell2010, 38, 291–304
256. Foster, B.A.; Coffey, H.A.; Morin, M.J.; Rastinejad, F. Pharmacological rescue of mutant p53 conformation and function. Science1999, 286, 2507–2510